Register Now for The Outlook on Active Nutrition
News|Articles|April 28, 2026

BGG Showcases Clinically Studied “Dream Team” Ingredients for Metabolic, Cognitive, and Sleep Health at Vitafoods Europe 2026

Author(s)Erin McEvoy
Listen
0:00 / 0:00

Key Takeaways

  • A multi-ingredient formulation strategy is emphasized to deliver broader “body and mind” benefits versus standalone actives, with attention to clinically supported outcomes and ingredient compatibility.
  • ApplePhenon is positioned for metabolic health, with human studies supporting weight management and improvements across three pillars: cardiovascular support, blood sugar reduction, and weight-related endpoints.
SHOW MORE

BGG will showcase three of its clinically studied ingredients—ApplePhenon, TheraPrimE, and AstaZine— highlighting human research supporting benefits and holistic wellness.

BGG will spotlight a science-driven, integrative approach to nutraceutical development at Vitafoods Europe 2026, where the company plans to introduce its “Dream Team” solutions targeting both physical and cognitive health. The portfolio brings together three of BGG’s flagship ingredients—ApplePhenon, TheraPrimE, and AstaZine—with an emphasis on clinically supported benefits and synergistic formulation strategies.

The concept addresses the health concerns of metabolic function, cognitive performance, and sleep quality, through multi-ingredient solutions. According to the press release, BGG is positioning these ingredients not as standalone actives, but as complementary components designed to deliver broader “body and mind” support.1 The company will also highlight a variety of delivery formats, including functional beverages, gummies, stick packs, dairy products, and snacks, underscoring the importance of consumer-friendly applications alongside scientific substantiation.

ApplePhenon for Metabolic Health

Among the three, ApplePhenon is positioned as providing for metabolic health. Derived from apples and standardized for its polyphenol content, the ingredient has been evaluated in multiple human clinical studies. These studies suggest that ApplePhenon supplementation may support weight management and improve metabolic markers. In an interview with Nutritional Outlook, Lixin Ding, chief scientific officer at BGG, explains that the structure of the ingredient produces a synergistic effect.2 “In terms of weight management or metabolic syndromes, it supports the benefits from three pillar aspect, which is the cardiovascular support and blood sugar reduction and the weight management,” he stated. “We have four human studies supporting the weight management and metabolic health through these three key pillars.”

At the show, Ding will provide more details on the scientific research during a presentation at the Nutraceuticals Showcase Theatre.

TheraPrimeE for Memory and Sleep Support

TheraPrimE, BGG’s tocotrienol-rich vitamin E complex, is positioned as a key ingredient for cognitive and sleep support. Published clinical research referenced in the press release indicates that supplementation with tocotrienols may contribute to improvements in memory and overall cognitive performance. In addition, study participants reported reductions in sleep disturbances and related symptoms.3

The Antioxidant AstaZine

AstaZine, a natural astaxanthin derived from microalgae is highlighted for its antioxidant and anti-inflammatory properties. The press release notes a randomized, double-blind, placebo-controlled study in which the combination of AstaZine and TheraPrimE resulted in significant improvements in both composite and verbal memory scores. This finding underscores the potential for synergistic effects when combining carotenoids with tocotrienols, particularly in formulations targeting cognitive health.

Supporting Multiple Dimensions of Wellness

Together, these ingredients form the basis of BGG’s “Dream Team” concept, which emphasizes the value of combining clinically studied actives to achieve multi-dimensional health benefits. “Consumers are looking for convenient and clinically supported solutions that help them look and feel great – and our Dream Team can provide the perfect match,” explains Tamara Higgins, BGG’s Managing Director for Americas and Head of Western Regional Sales. “ApplePhenon, TheraPrimE, and AstaZine are natural, science-backed, versatile ingredients that support total body and mind wellness.”

By grounding its formulations in published clinical research and demonstrating compatibility across multiple delivery systems, BGG aims to provide formulators with versatile, evidence-based tools for product innovation. As highlighted in the press release, the company’s showcase at Vitafoods Europe 2026 is intended to illustrate how targeted ingredient combinations can support the development of nutraceuticals designed to meet evolving expectations around efficacy, convenience, and holistic wellness.

Additional ingredients from BGG include ThinOgen fucoxanthin, Vitosa next-generation stevia, and licorice extracts.

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

  1. BGG. BGG to unveil ‘Dream Team’ solutions for body and mind at Vitafoods 2026. March 31, 2026. Accessed April 27, 2026. https://bgg.prezly.com/bgg-to-unveil-dream-team-solutions-for-body-and-mind-at-vitafoods-2026
  2. McEvoy E. BGG announces expansion of astaxanthin facility and research. May 16, 2026. Accessed April 27, 2026. https://www.nutritionaloutlook.com/view/bgg-announces-expansion-of-astaxanthin-facility-and-research
  3. Lopresti AL, Smith SJ, Ding L, Li Y and Zhang P. An examination into the effects of tocotrienols (TheraPrimE® rice) on cognitive abilities and sleep in healthy adults: a randomised, double-blind, placebo-controlled trial. Front. Nutr. 2025; 12:1621516. doi:10.3389/fnut.2025.1621516
  4. Sekikawa T, Kizawa Y, Li Y, Takara T. Cognitive function improvement with astaxanthin and tocotrienol intake: a randomized, double-blind, placebo-controlled study. J Clin Biochem Nutr. 2020;67(3):307-316. doi:10.3164/jcbn.19-116